Figure 2.
Cumulative incidence of severe acute respiratory syndrome coronavirus 2 infection ≥14 days after the second dose of a messenger RNA (mRNA) coronavirus disease 2019 (COVID-19) vaccine according to pregnancy status at the time of vaccination. The time axis reflects the number of days counting from 14 days after the second dose of an mRNA COVID-19 vaccine was administered.